Renaissance Group’s Fresenius Medical Care FMS Stock Holding History

Renaissance Group’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-377,246	Closed	-$15.3M	–	261
2019 Q1	$15.3M	Buy	377,246 +94,236	+33%	+$3.51M	0.61%	91
2018 Q4	$9.17M	Sell	283,010 -54,585	-16%	-$2.2M	0.42%	111
2018 Q3	$17.4M	Buy	+337,595	New	+$16.9M	0.61%	79

Other funds holding FMS

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Renaissance Group's FMS Position: Q2 2019 in Review

Renaissance Group sold out of Fresenius Medical Care (FMS) in Q2 2019, closing a stake of 377,246 shares — an estimated $15.3M sold.

Renaissance Group first reported a position in FMS in Q3 2018 and held it in 3 quarters. The position peaked at $17.4M in Q3 2018. 175 funds tracked by Wall St. Rank hold FMS as of Q2 2019.

Renaissance Group reported no remaining Fresenius Medical Care position as of Q2 2019 after selling out during the quarter.
Renaissance Group sold 377,246 Fresenius Medical Care shares in Q2 2019, an estimated $15.3M.
Renaissance Group first reported a position in Fresenius Medical Care in Q3 2018 and held it in 3 quarters.
Renaissance Group's Fresenius Medical Care position peaked at $17.4M in Q3 2018.
175 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2019.

Based on Renaissance Group's 13F filing for Q2 2019, filed 13 Aug 2019.